Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Quinones CM"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł :
Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement".
Autorzy :
Dupuis LL; Department of Pharmacy and Research Institute, The Hospital for Sick Children and Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
Quinones CM; Department of Population Sciences, Beckman Research Institute at City of Hope, Duarte, CA, USA.
Ritchie J; Pathology & Laboratory Medicine Department, Emory University, Atlanta, GA, USA.
Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Pediatrics, University of Washington, Seattle, WA, USA.
Bauters T; Chair, European Society for Blood and Marrow Transplantation (EBMT) Pharmacist Committee, Pediatric Hemato-Oncology & Stem Cell Transplantation, Ghent University Hospital, Belgium.
Yeh RF; Pharmacokinetics Laboratory, Seattle Cancer Care Alliance, Seattle, WA, USA.
Anasetti C; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Boelens JJ; Chief, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hamerschlak N; Hematology and Bone Marrow Transplantation Department, Hospital Israelita Albert Einstein, São Paulo Area, Brazil.
Hassan M; Division of Experimental Cancer Medicine, Department of Laboratory Medicine at Karolinska Institutet and Division of Clinical Research Centrum at Karolinska University Hospital, Stockholm, Sweden.
Kang HJ; Department of Pediatrics, Seoul National Univeristy College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Korea.
Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University and Division of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Paci A; Department of Pharmacology, Institute Gustave Roussy Cancer Center, Grand Paris, School of Pharmacy - Paris Sud University, France.
Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Shaw PJ; BMT Services, The Children's Hospital at Westmead, Westmead, New South Wales, and Discipline of Child and Adolescent Health, University of Sydney, Australia.
Seewaldt VL; Department of Population Sciences, Beckman Research Institute at City of Hope, Duarte, CA, USA.
Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Militano O; Pharmacist, Children's Oncology Group.
Pulsipher MA; Transplantation and Cellular Therapy Section, Children's Hospital Los Angeles Cancer and Blood Disease Institute, USC Keck School of Medicine, Los Angeles, CA, USA.
McCune JS; Department of Population Sciences, Beckman Research Institute at City of Hope, Duarte, CA, USA. Electronic address: .
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Sep; Vol. 26 (9), pp. e235-e236. Date of Electronic Publication: 2020 Jun 09.
Typ publikacji :
Letter; Comment
MeSH Terms :
Busulfan*
Plasma*
Consensus ; Humans
Opinia redakcyjna
Tytuł :
Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement.
Autorzy :
McCune JS; Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Pharmaceutics, University of Washington, Seattle, WA, USA; Molecular Prevention, Intervention and Technology Division, Beckman Research Institute, City of Hope, Duarte, CA, USA. Electronic address: .
Quinones CM; Molecular Prevention, Intervention and Technology Division, Beckman Research Institute at City of Hope, Duarte, CA, USA.
Ritchie J; Pathology & Laboratory Medicine Department, Emory University, Atlanta, GA, USA.
Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Pharmaceutics, University of Washington, Seattle, WA, USA.
van Maarseveen E; Clinical Pharmacology, University Medical Center Utrecht, Utrecht, Princess Maxima Center for Pediatric Oncology, Utrecht and Drug Analysis and Toxicology division (KKGT) of the Dutch Foundation for Quality Assessment in Medical Laboratories (SKML), Utrecht, Netherlands.
Yeh RF; Pharmacokinetics Laboratory, Seattle Cancer Care Alliance, Seattle, WA, USA.
Anasetti C; Department of Blood and Marrow Transplant, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Molecular Prevention, Intervention and Technology Division, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Boelens JJ; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands; Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hamerschlak N; Hematology and Bone Marrow Transplantation Department, Hospital Israelita Albert Einstein, São Paulo Area, Brazil.
Hassan M; Division of Experimental Cancer Medicine, Department of Laboratory Medicine at Karolinska Institutet and Division of Clinical Research Centrum at Karolinska University Hospital, Stockholm, Sweden.
Kang HJ; Department of Pediatrics, Seoul National Univeristy College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Korea.
Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University and Division of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Paci A; Department of Pharmacology, Institute Gustave Roussy Cancer Center, Grand Paris, School of Pharmacy - Paris Sud University, France.
Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical College New York, NY, USA.
Shaw PJ; BMT Services, The Children's Hospital at Westmead, Westmead, New South Wales, and Discipline of Child and Adolescent Health, University of Sydney, Australia.
Seewaldt VL; Molecular Prevention, Intervention and Technology Division, Beckman Research Institute at City of Hope, Duarte, CA, USA.
Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Hsieh A; Medical Content Manager at McKesson Specialty Health, Seattle, WA, USA.
Poon B; Department of Pharmacy, AdventHealth for Children, Orlando, FL, USA.
Mohty M; Department of Hematology and Cell Therapy, Acute Leukemia Working Party EBMT Paris Office, Hôpital Saint-Antoine, Paris, France.
Pulsipher MA; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, CA, USA.
Pasquini M; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Dupuis LL; Department of Pharmacy and Research Institute, The Hospital for Sick Children and Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2019 Sep; Vol. 25 (9), pp. 1890-1897. Date of Electronic Publication: 2019 May 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Busulfan*/administration & dosage
Busulfan*/pharmacokinetics
Consensus*
Databases, Factual*
Drug Monitoring*
Hematopoietic Stem Cell Transplantation*
Registries*
Allografts ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Induction of Cancer Cell Death by Hyaluronic Acid-Mediated Uptake of Cytochrome C.
Autorzy :
Figueroa CM; Department of Chemistry, University of Puerto Rico, Río Piedras Campus, San Juan, PR 00931, USA.
Morales-Cruz M; Department of Biology, University of Puerto Rico, Río Piedras Campus, San Juan, PR 00931, USA.
Suárez BN; Department of Chemistry, University of Puerto Rico, Río Piedras Campus, San Juan, PR 00931, USA.
Fernández JC; Department of Biology, University of Puerto Rico, Río Piedras Campus, San Juan, PR 00931, USA.
Molina AM; Department of Chemistry, University of Puerto Rico, Río Piedras Campus, San Juan, PR 00931, USA.
Quiñones CM; Department of Chemistry, University of Puerto Rico, Río Piedras Campus, San Juan, PR 00931, USA.
Griebenow K; Department of Chemistry, University of Puerto Rico, Río Piedras Campus, San Juan, PR 00931, USA.
Pokaż więcej
Źródło :
Journal of nanomedicine & nanotechnology [J Nanomed Nanotechnol] 2015 Oct; Vol. 6 (5). Date of Electronic Publication: 2015 Oct 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies